ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cipla launches Nintib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis
October 22, 2020Cipla has launched generic Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Available as 100 mg and 150 mg capsules, it will be marketed under the brand name Nintib. -
Boehringer Ingelheim files for regulatory approval of nintedanib
March 20, 2019Boehringer Ingelheim has filed regulatory submissions with the Food and Drug Administration (FDA) and European Medicines Agency (EMA) for approval of nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD). -
Aptuit and Chiesi initiate Integrated Discovery Project to identify novel compounds to treat Idiopat
January 18, 2017The agreement will integrate early discovery capabilities to identify promising compounds for further pre-clinical development.
Pharma Sources Insight January 2025
